Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population

Journal of Lipid Research

Volumn 51, Issue 2, 2010, Pages 422-430

  Hodolugil, Uur ^a   Williamson, David W ^a   Mahley, Robert W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heart disease risk; Lipoprotein metabolism; Single nucleotide polymorphisms

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; TRANSCRIPTION FACTOR; LIPH PROTEIN, HUMAN; TRIACYLGLYCEROL LIPASE;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DNA POLYMORPHISM; ENZYME ACTIVITY; EXON; FEMALE; GENE SEQUENCE; GENETIC CONSERVATION; GENOTYPE; HOMOZYGOTE; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; TURKEY (REPUBLIC); BLOOD; GENETICS; GENOMICS; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CHOLESTEROL, HDL; FEMALE; GENOMICS; GENOTYPE; HUMANS; LIPASE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS; TURKEY;

EID: 77949525949     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P001578     Document Type: Article

References (61)

1. Gordon, D. J., J. L. Probstfi eld, R. J. Garrison, J. D. Neaton, W. P. Castelli, J. D. Knoke, D. R. Jacobs, Jr., S. Bangdiwala, and H. A. Tyroler. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79: 8-15.
2. Jacobs, D. R., Jr., I. L. Mebane, S. I. Bangdiwala, M. H. Criqui, and H. A. Tyroler. 1990. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am. J. Epidemiol. 131: 32-47.
3. Murray, C. J. L., and A. D. Lopez. 1997. Mortality by cause for eight regions of the world: Global Burden of Disease study. Lancet. 349: 1269-1276.
4. Mahaney, M. C., J. Blangero, D. L. Rainwater, A. G. Comuzzie, J. L. VandeBerg, M. P. Stern, J. W. MacCluer, and J. E. Hixson. 1995. A major locus infl uencing plasma high-density lipoprotein cholesterol levels in the San Antonio Family Heart Study: segregation and linkage analyses. Arterioscler. Thromb. Vasc. Biol. 15: 1730-1739.
5. Knoblauch, H., A. Bauerfeind, M. R. Toliat, C. Becker, T. Luganskaja, U. P. Günther, K. Rohde, H. Schuster, C. Junghans, F. C. Luft, et al. 2004. Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipopro-tein and low-density lipoprotein cholesterol. Hum. Mol. Genet. 13: 993-1004.
6. Yu, Y., D. F. Wyszynski, D. M. Waterworth, S. D. Wilton, P. J. Barter, Y. A. Kesäniemi, R. W. Mahley, R. McPherson, G. Waeber, T. P. Bersot, et al. 2005. Multiple QTLs infl uencing triglyceride and HDL and total cholesterol levels identifi ed in families with athero-genic dyslipidemia. J. Lipid Res. 46: 2202-2213.
7. Wyszynski, D. F., D. M. Waterworth, P. J. Barter, J. Cohen, Y. A. Kesäniemi, R. W. Mahley, R. McPherson, G. Waeber, T. P. Bersot, S. S. Sharma, et al. 2005. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III defi nition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am. J. Cardiol. 95: 194-198.
8. Mahley, R. W., K. H. Weisgraber, and T. P. Bersot. 2008. Disorders of lipid metabolism. In Williams Textbook of Endocrinology. H. M. Kronenberg, S. Melmed, K. S. Polonsky, and P. R. Larsen, editors. Saunders, Philadelphia. 1589-1653.
9. Guerra, R., J. Wang, S. M. Grundy, and J. C. Cohen. 1997. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 94: 4532-4537.
10. Couture, P., J. D. Otvos, L. A. Cupples, C. Lahoz, P. W. F. Wilson, E. J. Schaefer, and J. M. Ordovas. 2000. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipopro-tein subclass profi les: the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 20: 815-822.
11. Murtomäki, S., E. Tahvanainen, M. Antikainen, L. Tiret, V. Nicaud, H. Jansen, and C. Ehnholm. 1997. Hepatic lipase gene polymorphisms infl uence plasma HDL levels. Results from Finnish EARS participants. Arterioscler. Thromb. Vasc. Biol. 17: 1879-1884.
12. Andersen, R. V., H. H. Wittrup, A. Tybjærg-Hansen, R. Steffensen, P. Schnohr, and B. G. Nordestgaard. 2003. Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study. J. Am. Coll. Cardiol. 41: 1972-1982.
13. Kathiresan, S., O. Melander, D. Anevski, C. Guiducci, N. P. Burtt, C. Roos, J. N. Hirschhorn, G. Berglund, B. Hedblad, L. Groop, et al. 2008. Polymorphisms associated with cholesterol and risk of cardiovascular events. N. Engl. J. Med. 358: 1240-1249.
14. Vega, G. L., J. Gao, T. P. Bersot, R. W. Mahley, R. Verstraete, S. M. Grundy, A. White, and J. C. Cohen. 1998. The-514 polymorphism in the hepatic lipase gene (LIPC) does not infl uence androgen-mediated stimulation of hepatic lipase activity. J. Lipid Res. 39: 1520-1524.
15. Nie, L., J. Wang, L. T. Clark, A. Tang, G. L. Vega, S. M. Grundy, and J. C. Cohen. 1998. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly infl uence postheparin plasma hepatic lipase activity. J. Lipid Res. 39: 1127-1130.
16. Nie, L., S. Niu, G. L. Vega, L. T. Clark, A. Tang, S. M. Grundy, and J. C. Cohen. 1998. Three polymorphisms associated with low hepatic lipase activity are common in African Americans. J. Lipid Res. 39: 1900-1903.
17. Hegele, R. A., L. Tu, and P. W. Connelly. 1992. Human hepatic lipase mutations and polymorphisms. Hum. Mutat. 1: 320-324.
18. Cohen, J. C., Z. Wang, S. M. Grundy, M. R. Stoesz, and R. Guerra. 1994. Variation at the hepatic lipase and apolipoprotein AI/CIII/ AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94: 2377-2384.
19. Allayee, H., K. M. Dominguez, B. E. Aouizerat, R. M. Krauss, J. I. Rotter, J. Lu, R. M. Cantor, T. W. A. de Bruin, and A. J. Lusis. 2000. Contribution of the hepatic lipase gene to the atherogenic lipopro-tein phenotype in familial combined hyperlipidemia. J. Lipid Res. 41: 245-252.
20. Willer, C. J., S. Sanna, A. U. Jackson, A. Scuteri, L. L. Bonnycastle, R. Clarke, S. C. Heath, N. J. Timpson, S. S. Najjar, H. M. Stringham, et al. 2008. Newly identifi ed loci that infl uence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40: 161-169.
21. Kathiresan, S., O. Melander, C. Guiducci, A. Surti, N. P. Burtt, M. J. Rieder, G. M. Cooper, C. Roos, B. F. Voight, A. S. Havulinna, et al. 2008. Six new loci associated with blood low-density lipopro-tein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40: 189-197.
22. Kooner, J. S., J. C. Chambers, C. A. Aguilar-Salinas, D. A. Hinds, C. L. Hyde, G. R. Warnes, F. J. Gómez Pérez, K. A. Frazer, P. Elliott, J. Scott, et al. 2008. Genome-wide scan identifi es variation in MLXIPL associated with plasma triglycerides. Nat. Genet. 40: 149-151.
23. McCarthy, M. I., G. R. Abecasis, L. R. Cardon, D. B. Goldstein, J. Little, J. P. A. Ioannidis, and J. N. Hirschhorn. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9: 356-369.
24. Mahley, R. W., K. E. Palao?lu, Z. Atak, J. Dawson-Pepin, A-M. Langlois, V. Cheung, H. Onat, P. Fulks, L. L. Mahley, F. Vakar, et al. 1995. Turkish Heart Study: lipids, lipoproteins, and apolipo-proteins. J. Lipid Res. 36: 839-859.
25. Mahley, R. W., S. Can, S. Özbayrakç?, T. P. Bersot, S. Tanir, K. E. Palao?lu, and G. M. Pépin. 2005. Modulation of high-density lipo-proteins in a population in Istanbul, Turkey, with low levels of high-density lipoproteins. Am. J. Cardiol. 96: 547-555.
26. Tezcan, S., H. Alt?nta?, R. Sönmez, A. Akinci, B. Do?an, B. Çak?r, Y. Bilgin, H. U. Klör, and O. Razum. 2003. Cardiovascular risk factor levels in a lower middle-class community in Ankara, Turkey. Trop. Med. Int. Health. 8: 660-667.
27. Porsch-Oezçueruemez, M., Y. Bilgin, M. Wollny, A. Gediz, A. Arat, E. Karatay, A. Akinci, K. Sinterhauf, H. Koch, I. Siegfried, et al. 1999. Prevalence of risk factors of coronary heart disease in Turks living in Germany: the Giessen Study. Atherosclerosis. 144: 185-198.
28. Bersot, T. P., G. L. Vega, S. M. Grundy, K. E. Palao?lu, P. Atagündüz, S. Özbayrakçi, O. Gökdemir, and R. W. Mahley. 1999. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J. Lipid Res. 40: 432-438.
29. Shohet, R. V., G. L. Vega, T. P. Bersot, R. W. Mahley, S. M. Grundy, R. Guerra, and J. C. Cohen. 2002. Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC). Hum. Mutat. 19: 536-542
30. The International HapMap Consortium. 2007. A second genera-tion human haplotype map of over 3.1 million SNPs. Nature. 449: 851-861.
31. Hinds, D. A., L. L. Stuve, G. B. Nilsen, E. Halperin, E. Eskin, D. G. Ballinger, K. A. Frazer, and D. R. Cox. 2005. Whole-genome patterns of common DNA variation in three human populations. Science. 307: 1072-1079.
32. De La Vega, F. M., H. I. Isaac, and C. R. Scafe. 2006. A tool for selecting SNPs for association studies based on observed linkage disequilibrium patterns. Pac. Symp. Biocomput. 11: 487-498
33. The ENCODE Project Consortium. 2007. Identifi cation and anal-ysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 447: 799-816.
34. Ovcharenko, I., M. A. Nobrega, G. G. Loots, and L. Stubbs. 2004. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res. 32: W280-W286.
35. Siepel, A., G. Bejerano, J. S. Pedersen, A. S. Hinrichs, M. Hou, K. Rosenbloom, H. Clawson, J. Spieth, L. W. Hillier, S. Richards, et al. 2005. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 15: 1034-1050.
36. ®: transcriptional regulation, from patterns to profi les. Nucleic Acids Res. 31: 374-378.
37. Blanchette, M., A. R. Bataille, X. Chen, C. Poitras, J. Laganière, C. Lefèbvre, G. Deblois, V. Giguère, V. Ferretti, D. Bergeron, et al. 2006. Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expres sion. Genome Res. 16: 656-668.
38. Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M. A. R. Ferreira, D. Bender, J. Maller, P. Sklar, P. I. W. de Bakker, M. J. Daly, et al. 2007. PLINK: a tool set for whole-genome association and popula tion-based linkage analyses. Am. J. Hum. Genet. 81: 559-575.
39. Corbex, M., O. Poirier, F. Fumeron, D. Betoulle, A. Evans, J. B. Ruidavets, D. Arveiler, G. Luc, L. Tiret, and F. Cambien. 2000. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional poly-morphisms and gene-environment interaction. Genet. Epidemiol. 19: 64-80.
40. Barrett, J. C, B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21: 263-265.
41. Ng, P. C, and S. Henikoff. 2002. Accounting for human poly-morphisms predicted to affect protein function. Genome Res. 12: 436-446.
42. Sunyaev, S., V. Ramensky, I. Koch, W. Lathe III, A. S. Kondrashov, and P. Bork. 2001. Prediction of deleterious human alleles. Hum. Mol. Genet. 10: 591-597.
43. Deeb, S. S., and R. Peng. 2000. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J. Lipid Res. 41: 155-158.
44. Botma, G-J., A. J. M. Verhoeven, and H. Jansen. 2001. Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor. Atherosclerosis. 154: 625-632.
45. van't Hooft, F. M., B. Lundahl, F. Ragogna, F. Karpe, G. Olivecrona, and A. Hamsten. 2000. Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. Arterioscler. Thromb. Vasc. Biol. 20: 1335-1339.
46. Schadt, E. E., C. Molony, E. Chudin, K. Hao, X. Yang, P. Y. Lum, A. Kasarskis, B. Zhang, S. Wang, C. Suver, et al. 2008. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6: e107
47. Rufi bach, L. E., S. A. Duncan, M. Battle, and S. S. Deeb. 2006. Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter. J. Lipid Res. 47: 1463-1477.
48. 3. Biochim. Biophys. Acta. 1737: 16-26.
49. Jiang, W., T. Miyamoto, T. Kakizawa, S-I. Nishio, A. Oiwa, T. Takeda, S. Suzuki, and K. Hashizume. 2006. Inhibition of LXRa signaling by vitamin D receptor: possible role of VDR in bile acid synthesis. Biochem. Biophys. Res. Commun. 351: 176-184.
50. Knudsen, P., M. Antikainen, S. Ehnholm, M. Uusi-Oukari, H. Tenkanen, S. Lahdenperä, J. Kahri, M. Tilly-Kiesi, A. Bensadoun, M-R. Taskinen, et al. 1996. A compound heterozygote for hepatic lipase gene mutations Leu334 \> Phe and Thr383 \> Met: correlation between hepatic lipase activity and phenotypic expression. J. Lipid Res. 37: 825-834.
51. Knudsen, P., M. Antikainen, M. Uusi-Oukari, S. Ehnholm, S. Lahdenperä, A. Bensadoun, H. Funke, H. Wiebusch, G. Assmann, M-R. Taskinen, et al. 1997. Heterozygous hepatic lipase defi ciency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis. 128: 165-174.
52. Hegele, R. A., J. A. Little, C. Vezina, G. F. Maguire, L. Tu, T. S. Wolever, D. J. A. Jenkins, and P. W. Connelly. 1993. Hepatic lipase defi ciency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13: 720-728.
53. Baroni, M. G., A. Berni, S. Romeo, M. Arca, T. Tesorio, G. Sorropago, U. Di Mario, and D. J. Galton. 2003. Genetic study of common variants at the apo E, apo AI, apo CIII, apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. BMC Med. Genet. 4: 8.
54. Su, Z., S. Zhang, D. W. Nebert, L. Zhang, D. Huang, Y. Hou, L. Liao, and C. Xiao. 2002. A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity. J. Lipid Res. 43: 1595-1601.
55. Su, Z-G., S-Z. Zhang, Y-P. Hou, L. Zhang, D-J. Huang, L-C. Liao, and C-Y. Xiao. 2002. Relationship between a novel polymorphism of hepatic lipase gene and coronary artery disease. Acta Biochim. Biophys. Sin. (Shanghai). 34: 780-785. (Pubitemid 36069011)
56. +884 → G in the hepatic lipase gene and its association with coronary artery disease. Acta Biochim. Biophys. Sin. (Shanghai). 35: 606-610.
57. Wheeler, D. A., M. Srinivasan, M. Egholm, Y. Shen, L. Chen, A. McGuire, W. He, Y-J. Chen, V. Makhijani, G. T. Roth, et al. 2008. The complete genome of an individual by massively parallel DNA sequencing. Nature. 452: 872-876.
58. Levy, S., G. Sutton, P. C. Ng, L. Feuk, A. L. Halpern, B. P. Walenz, N. Axelrod, J. Huang, E. F. Kirkness, G. Denisov, et al. 2007. The diploid genome sequence of an individual human. PLoS Biol. 5: e254.
59. Wang, J., W. Wang, R. Li, Y. Li, G. Tian, L. Goodman, W. Fan, J. Zhang, J. Li, J. Zhang, et al. 2008. The diploid genome sequence of an Asian individual. Nature. 456: 60-65.
60. Cohen, J. C., R. S. Kiss, A. Pertsemlidis, Y. L. Marcel, R. McPherson, and H. H. Hobbs. 2004. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 305: 869-872.
61. Cohen, J. C., A. Pertsemlidis, S. Fahmi, S. Esmail, G. L. Vega, S. M. Grundy, and H. H. Hobbs. 2006. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc. Natl. Acad. Sci. USA. 103: 1810-1815.